Dr. Kris’ Blog
Welcome to my blog! This is where you’ll find my latest updates on everything optometry and how the team and I at Today’s Vision are working hard to better serve you!
Many of my patients ask me questions about Latisse and want to know more about it.
LATISSE® (bimatoprost ophthalmic solution) 0.03%, approved by the U.S. Food and Drug Administration (FDA) in 2008, is a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE® is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
Latisse is a 16 week treatment. It is applied similar to mascara but used only at night time.
The active ingredient in Latisse is bimatoprost, which is an FDA approved drug used to treat glaucoma and manage ocular pressure.
Some of the most common side effects of Latisse include redness of the eye and an itching sensation at the application site. The product may also cause eye irritation or dryness. In some cases, users of Latisse noticed hyperpigmentation (darkening of the skin) around the area where the formula was applied, but is rare in patients. This condition may be reversible after you stop using the product.
There are no comments yet.